These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 15829181)
1. Adenosine and the regulation of cerebral blood flow. O'Regan M Neurol Res; 2005 Mar; 27(2):175-81. PubMed ID: 15829181 [TBL] [Abstract][Full Text] [Related]
2. Adenosine receptor inhibition with theophylline attenuates the skin blood flow response to local heating in humans. Fieger SM; Wong BJ Exp Physiol; 2010 Sep; 95(9):946-54. PubMed ID: 20562295 [TBL] [Abstract][Full Text] [Related]
3. The role of adenosine in hypercarbic hyperemia: in vivo and in vitro studies in adenosine 2(A) receptor knockout and wild-type mice. Miekisiak G; Yoo K; Sandler AL; Kulik TB; Chen JF; Winn HR J Neurosurg; 2009 May; 110(5):981-8. PubMed ID: 19199466 [TBL] [Abstract][Full Text] [Related]
4. Correlation of intrinsic optical signal, cerebral blood flow, and evoked potentials during activation of rat somatosensory cortex. Haglund MM; Meno JR; Hochman DW; Ngai AC; Winn HR J Neurosurg; 2008 Oct; 109(4):654-63. PubMed ID: 18826352 [TBL] [Abstract][Full Text] [Related]
5. Adenosine's role in hypercapnia-evoked cerebral vasodilation in the rat. Phillis JW; Lungu CL; Barbu DE; O'Regan MH Neurosci Lett; 2004 Jul; 365(1):6-9. PubMed ID: 15234462 [TBL] [Abstract][Full Text] [Related]
6. Functional characterization of coronary vascular adenosine receptors in the mouse. Flood A; Headrick JP Br J Pharmacol; 2001 Aug; 133(7):1063-72. PubMed ID: 11487517 [TBL] [Abstract][Full Text] [Related]
7. [Cerebral blood flow function during altered cholinergic mediation]. Priputina LS; Predtechenskiĭ MB; Levkovich IuI Fiziol Zh SSSR Im I M Sechenova; 1989 Nov; 75(11):1589-95. PubMed ID: 2628016 [TBL] [Abstract][Full Text] [Related]
8. Adenosine A(2A) receptors in portal hypertension: their role in the abnormal response to adenosine of the cranial mesenteric artery in rabbits. de Brito MT; Canto A; Correia JH; Cunha RA; Marques MC Br J Pharmacol; 2002 Mar; 135(5):1324-30. PubMed ID: 11877342 [TBL] [Abstract][Full Text] [Related]
9. The role and regulation of adenosine in the central nervous system. Dunwiddie TV; Masino SA Annu Rev Neurosci; 2001; 24():31-55. PubMed ID: 11283304 [TBL] [Abstract][Full Text] [Related]
10. A novel mechanism of vasoregulation: ADP-induced relaxation of the porcine isolated coronary artery is mediated via adenosine release. Rayment SJ; Ralevic V; Barrett DA; Cordell R; Alexander SP FASEB J; 2007 Feb; 21(2):577-85. PubMed ID: 17167068 [TBL] [Abstract][Full Text] [Related]
11. On the role of subtype selective adenosine receptor agonists during proliferation and osteogenic differentiation of human primary bone marrow stromal cells. Costa MA; Barbosa A; Neto E; Sá-e-Sousa A; Freitas R; Neves JM; Magalhães-Cardoso T; Ferreirinha F; Correia-de-Sá P J Cell Physiol; 2011 May; 226(5):1353-66. PubMed ID: 20945394 [TBL] [Abstract][Full Text] [Related]
12. Cardioprotective effects of adenosine A1 and A2A receptor agonists in the isolated rat heart. Lozza G; Conti A; Ongini E; Monopoli A Pharmacol Res; 1997 Jan; 35(1):57-64. PubMed ID: 9149317 [TBL] [Abstract][Full Text] [Related]
13. Adenosine receptor blockade and nitric oxide synthase inhibition in the retina: impact upon post-ischemic hyperemia and the electroretinogram. Ostwald P; Park SS; Toledano AY; Roth S Vision Res; 1997 Dec; 37(24):3453-61. PubMed ID: 9425522 [TBL] [Abstract][Full Text] [Related]
14. Newer targets for modulation of intraocular pressure: focus on adenosine receptor signaling pathways. Agarwal R; Agarwal P Expert Opin Ther Targets; 2014 May; 18(5):527-39. PubMed ID: 24579961 [TBL] [Abstract][Full Text] [Related]
15. Adenosinergic mechanisms underlying recovery of diaphragm motor function following upper cervical spinal cord injury: potential therapeutic implications. Nantwi KD; Goshgarian HG Neurol Res; 2005 Mar; 27(2):195-205. PubMed ID: 15829183 [TBL] [Abstract][Full Text] [Related]
16. Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists. Gao Z; Li Z; Baker SP; Lasley RD; Meyer S; Elzein E; Palle V; Zablocki JA; Blackburn B; Belardinelli L J Pharmacol Exp Ther; 2001 Jul; 298(1):209-18. PubMed ID: 11408544 [TBL] [Abstract][Full Text] [Related]
17. Adenosine receptors as targets for drug development. Fredholm BB Drug News Perspect; 2003 Jun; 16(5):283-9. PubMed ID: 12942159 [TBL] [Abstract][Full Text] [Related]